Although it’s trying to keep quiet about its product, a medical device startup developing a new treatment for obesity revealed this week it’s in the middle of raising $5.5 million. According to a recently filed U.S. Securities and Exchange Commission document, Vibrynt Inc. has raised half of a $5.5 million offering from five investors. Vibrynt’s […]
Freedom Meditech has submitted a 510(k) application for regulatory clearance of its medical device that can be used to detect chronic disease. The company’s ClearPath DS-120 Lens Fluorescence Biomicroscope noninvasively scans the eye to identify patients with signs of degenerative changes in the lens of the eye, according to a statement from San Diego-based Freedom […]
Richard T. Clark, chairman and former CEO of Merck & Co. of Whitehouse Station, New Jersey, will retire from the company and its board of directors effective Dec. 1 . Kenneth C. Frazier, the current president and CEO, will become the new chairman. Frazier joined the drug company in 1992 as general counsel. He presided […]
Next-generation insulin developer Thermalin Diabetes is targeting an $8 million series B round of investment that would fund the first in-human studies of its insulin analogs. A successful clinical trial — though a long way off for the Cleveland-based company — would represent a huge milestone for Thermalin. CEO Rick Berenson said a positive trial […]
Glytec, a company whose technology helps diabetics monitor and manage their blood glucose levels, has raised $8.27 million in equity financing that the company will use to support growth in the United States and abroad, as well as for continued research and development. According to securities filings, the glycemic management systems company’s parent targeted the […]
A mobile health IT startup from Youngstown, Ohio has ambitious plans to lead the development of a wellness network that would connect patients, restaurants, grocery stores, health insurance companies, employers and doctors. Wellness Integrated Network (WIN) aims to use the massive amounts of data that would be housed on its network to develop diet plans […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
An online diabetes support network has added an education program that it hopes will fill what it calls a gap in helping diabetic patients manage their condition. The new “Diabetes Daily University” will offer both free and paid classes, with its first class called “Workshop for Better Blood Sugars” that will be taught by a […]
Medtronic Inc. (NYSE:MDT) isn’t in an uproar over recent reports of a hacked insulin pump that could discretely deliver dangerous doses of insulin to a wearer. “To our knowledge, there has never been a single reported incident outside of controlled laboratory experiments in more than 30 years of device telemetry use, which includes millions of […]
A path to better health and wellness can be as easy as putting one foot in front of the other. That is one of the ideas behind the innovative and creative “Walk with a Doc” program created by Ohio State Medical Association (OSMA) member David Sabgir, MD, a Columbus cardiologist. The program encourages increased healthy […]
A type 2 diabetes drug hopefully thought of as a potential blockbuster before stalling amid safety concerns is now taking another shot at approval. Takeda Pharmaceuticals (TYO:4502), which is partnered with Morrisville, North Carolina-based Furiex Pharmaceuticals (NASDAQ:FURX) on the diabetes drug candidate alogliptin, has filed two new drug applications for the compound with the U.S. […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Minnesota diabetes startup Exsulin, which is developing a drug to treat Type I diabetes, is trying to raise $25 million to help fund a large clinical trial next year. CEO and co-founder Lisa Jansa, who has been slowly building the Burnsville company, said that Exsulin is looking to raise money from research universities that may be […]
A company that’s developing a noninvasive blood glucose monitoring system for diabetics is hoping to raise $2.5 million to boost its staff and test its device. And Columbus, Ohio-based DIRAmed said it would be willing to move out of the state if it can land new investment, CEO Will Shain said. “We are currently considering […]
More than 13,500 people are gathered in San Diego at the 71st annual scientific conference of the American Diabetes Assn. to lead the fight against diabetes, a disease that affects more than 26 million children and adults in the U.S., according to the ADA. By 2020, the ADA estimates that more than half of adult […]
Diabetes drug development company Lumena Pharmaceuticals aims to harness a benefit that diabetics receive from gastric bypass surgery and deliver it to those patients in the form of a pill. The Durham, North Carolina-based company plans to start clinical trials on its experimental drug this year. To get there, Lumena has raised $500,000 in a […]
The U.S. Food and Drug Administration issued draft guidance yesterday aimed at advancing the approval of artificial pancreas systems for treatment of type 1 diabetes. The document addressed premarket approval and investigational device exemption for low glucose suspend devices, artificial pancreas systems that help reduce the severity of a drop in glucose levels by automatically […]
